As of August 2026, 28 paid clinical trials are recruiting for Oncology in Torrance, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Torrance, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Torrance Memorial Physician Network - Cancer Care | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 21 |
| City of Hope South Bay | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain | 17 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Atherosclerosis, C. Diff Infection, C.Difficile Diarrhea | 8 |
| Harbor-UCLA Medical Center | Diabetes Mellitus, Type 1, End-Stage Renal Disease, Heart Failure | 5 |
| Neurocrine Clinical Site | Schizophrenia, Tardive Dyskinesia | 4 |
| Torrance Memorial Medical Center | AMI Cardiogenic Shock, Aortic Stenosis, Coronary Artery Disease | 4 |
| Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center | Acute Myocardial Infarction, Diabetes Mellitus, Type 2, Heart Failure | 4 |
| Collaborative Neuroscience Research, LLC | Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features, Schizophrenia | 3 |
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center | Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Moderate Aortic Valve Stenosis, Peripheral Arterial Disease | 3 |
| The Lundquist Institute | ASCVD, ASCVD Management, Atherosclerosis Cardiovascular Disease | 3 |
| The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 3 |
| UCLA Hematology/Oncology - Torrance | Urothelial Carcinoma, Advanced/Metastatic Urothelial Cancer, Cancer of the Prostate | 3 |
| Breathe Clear Institute | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis Without Nasal Polyps | 2 |
| CS Cancer at the Hunt Cancer Center | Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Carcinoma | 2 |
| City of Hope at South Bay | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| GSK Investigational Site | Multiple Myeloma, Neoplasms, Head and Neck | 2 |
| Harbor UCLA Medical Center | Hypertension, Ketamine Infusion, Myocardial Infarction | 2 |
| Hunt Cancer Institute, an Affiliate of CS Cancer | Early Stage Triple-Negative Breast Carcinoma, TNBC, TNBC - Triple-Negative Breast Cancer | 2 |
| Lundquist Inst BioMed at Harbor | Chronic Myelogenous Leukemia - Chronic Phase, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors | 2 |
| Macula Retina Vitreous Research Institute | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-related Macular Degeneration | 2 |
| Retina Macula Institute | Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Degeneration | 2 |
| The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente | B-Cell Non-Hodgkins Lymphoma, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 2 |
| Torrance Memorial Physicians Network | Colorectal Neoplasms | 2 |
| Genesis Research LLC | Non-muscle Invasive Bladder Cancer, Carcinoma in Situ, Non-Muscle Invasive Bladder Neoplasms | 2 |
Recruiting trials in Torrance grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 164 recruiting clinical trials in Torrance, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Torrance compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Torrance include Anatomic Stage II Breast Cancer AJCC v8 (5), Breast Cancer (5), Schizophrenia (5), Stage IV Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Torrance on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Torrance include Torrance Memorial Physician Network - Cancer Care, City of Hope South Bay, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Torrance are Cancer & tumors (56), Cardiovascular (15), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.